Jacob S. Young received his BS in Neuroscience from Duke
University, Durham, NC in 2012, and his MD in Medicine from University of
Chicago, Chicago, IL, in 2017. He is a neurosurgery resident with an interest in
neurosurgical oncology and immunotherapy. His translational research focuses on
investigating novel viral and immunological agents for the treatment of
high-grade gliomas, and his clinical research explores how to optimize
the functional outcomes and minimize complications after surgery on intrinsic
brain tumors. His research accomplishments have been recognized at the
institutional, regional, and national levels and include receiving the Peter
Huttenlocher & Douglas Buchanan Prize and the Brain Research Foundation
Award from the University of Chicago, the Harold Rosegay Award from the San
Francisco Neurosurgical Society, and the Donald O. Quest award from the
American Association of Neurological Surgeons. His work has been funded by the
American Association of Neurological Surgeons and the Neurosurgery Research
Education Fund. His clinical performance was recognized with the Krevan’s Award
for Excellence in Patient Care at the Zuckerberg San Francisco General
Hospital, the Howard Naffziger Award for Outstanding Clinical Service and Care
to Neurosurgical Patients at UCSF, and the Exceptional Physician Award from
UCSF.
Katie Scotford has a BA in Sustainability and currently conducts neurosurgical research using stimulated Raman histology as an intraoperative tool for brain tumors. Her research interests include gliomas, the extent of resection, pseudoprogression versus tumor progression, prosopagnosia, mental health outcomes post-brain cancer treatment, and sustainability in healthcare.
Mitchel S. Berger received his bachelor's degree from
Harvard College in 1975 and his M.D. from the University of Miami Miller School
of Medicine in 1979. He completed an internship and a residency at UCSF and was
awarded a clinical fellowship in neuro-oncology by the American Cancer Society
and a research fellowship by the Brain Tumor Research Center. He completed
further fellowship training in neuro-oncology at UCSF and in pediatric
neurosurgery at the Hospital for Sick Children, an affiliate of the University
of Toronto. He is currently the Principal Investigator of UCSF's SPORE Brain
Tumor Program, funded by the National Cancer Institute and NINDS. He was also
named to the Blue Ribbon Panel for the National Cancer Moonshot Initiative. His
current research interests involve identifying molecular markers in gliomas as
correlates of tumor progression and prognosis.
